Utility of 18FDOPA PET/MRI for Focal Hyperinsulinism

Last updated: July 24, 2023
Sponsor: Washington University School of Medicine
Overall Status: Active - Recruiting

Phase

2

Condition

Primary Insulin Hypersecretion

Treatment

18F-Fluoro Dopa PET/MRI Imaging

Clinical Study ID

NCT05088798
201801029
  • All Genders

Study Summary

The purpose of the study is to provide access to 18F-DOPA PET to patients at Washington University and assess the utility of 18F-DOPA PET/MRI as a preoperative tool to detect and localize focal lesions in the pancreas that are causing hyperinsulinism.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Patients with confirmed hyperinsulinemic hypoglycemia, diagnosed by elevated insulinlevels during hypoglycemia and/or response to glucagon stimulation.
  2. Subjects who failed pharmacological therapy with diazoxide or octreotide.
  3. Subjects with signed informed consent by themselves or their parents or legalguardians.
  4. Patient's Endocrinologist has determined that the patient cannot be safely managedwith standard medical therapy (failed) and surgery is recommended to prevent futureepisodes of severe hypoglycemia and preserve brain function.

Exclusion

Exclusion Criteria:

  1. Any other major illness or condition that in the investigator's judgment willsubstantially increase the risk associated with the subject's participation in thisstudy.
  2. Patient must not have any contraindication to MRI as evaluated by a standardized MRIsafety questionnaire. If MRI is contraindicated, and patient meets inclusion criteriaand has no other contraindications study will be conducted in PET/CT scanner.
  3. Cases in which surgery will not be considered by parents or guardians.

Study Design

Total Participants: 100
Treatment Group(s): 1
Primary Treatment: 18F-Fluoro Dopa PET/MRI Imaging
Phase: 2
Study Start date:
September 10, 2020
Estimated Completion Date:
January 01, 2030

Study Description

Congenital hyperinsulinism (CHI) is a clinically and genetically heterogeneous disorder that is the most common cause of permanent hypoglycemia in infants and children. More than 50% of the medically-unresponsive patients have focal disease. Which is characterized by a distinct region of Beta-cell hyperplasia in the pancreas, due to a somatic loss of a gene that regulates cell proliferation. Resection of the involved region cures most cases of focal HI. Therefore, preoperative identification and localization of focal HI lesions is useful for diagnostic confirmation and surgical guidance of patients with HI that fail pharmacological therapy and are being considered for surgery.

Insulinomas are benign insulin secreting neuroendocrine neoplasms located in the pancreas. They are the most common cause of endogenous hyperinsulinemic hypoglycemia in adults. Approximately 90% are solitary, benign and < 2cm in diameter and therefore represent a challenge to localize. The small size of insulinomas makes detection by conventional imaging techniques such as contrast-enhanced CT (ceCT) and contrast-enhanced MRI challenging. As surgery appears to be the only available treatment option, it remains very critical to localize the tumor to facilitate pancreas preserving surgery. Endoscopic ultrasound is well established in the detection of insulinomas. However, this technique is operator dependent, invasive, and the visualization of the pancreas tail is not always possible. Therefore better imaging techniques to detect these lesions are needed for surgical planning.

Though not FDA approved, noninvasive imaging with 18F-fluoro-L-DOPA (FDOPA) is considered an integral part of standards of care management to identify focal lesions in CHI and potentially insulinomas. This is based on the fact that 18F-DOPA is selectively taken up by neuroendocrine cells, and thus, in focal HI, dense collections of endocrine cells can be visualized by an experienced radiologist. This study aims to determine if using combined positron emission tomography and magnetic resonance imaging will better localize the lesions and help the investigators determine which areas of the pancreas are affected, and assist with the surgical plan.

Connect with a study center

  • Washington University

    Saint Louis, Missouri 63110
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.